Tanzania - The East Africa Centre of Excellence on Skills and Tertiary Education in Biomedical Science Phase II (AFDB-P-Z1-I00-029)

Countries
  • Kenya
  • Rwanda
  • Tanzania
  • Uganda
Geographic location where the impacts of the investment may be experienced.
Financial Institutions
  • African Development Bank (AFDB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Approved
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
B
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Voting Date
Nov 27, 2024
Date when project documentation and funding is reviewed by the Board for consideration and approval. Some development banks will state a "board date" or "decision date." When funding approval is obtained, the legal documents are accepted and signed, the implementation phase begins.
Borrower
*Borrower information not provided at the time of disclosure*
A public entity (government or state-owned) provided with funds or financial support to manage and/or implement a project.
Sectors
  • Education and Health
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Loan
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 75.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Loan Amount (USD)
$ 75.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Bank Documents
Primary Source

Original disclosure @ AFDB website

Updated in EWS Jun 4, 2025


Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.

According to bank provided information, the first phase involved setting up a network of centers of excellence: Tanzania: Cardiovascular Sciences, Kenya: Nephrological and Urological Sciences, Uganda: Oncological Sciences, and Rwanda: Biomedical Engineering and eHealth, with a focus on regional coordination and mutual recognition to facilitate skills mobility within the region. Phase 1 was successfully completed in 2023, and lessons learned from its implementation have informed the design of Phase 2 of the project. This project will contribute directly to the achievement of Sustainable Development Goal 3 (good health and well-being), in particular the indicator relating to the reduction by one-third of premature mortality due to cardiovascular and other non-communicable diseases by 2030. It will also contribute to MDGs 4 (quality education), 5 (gender equality) and 10 (reducing inequalities between and within countries). The project is aligned with the EAC Common Market Protocol as regards the free movement of workers, the right of residence and the free movement of services.

Globally, cardiovascular diseases account for 17 million deaths annually. According to the WHO 2022 report, approximately 37% of premature deaths in East Africa are caused by cardiovascular diseases. Most of these deaths could have been averted by primary prevention or instituting lifesaving procedures that are not necessarily expensive provided skilled human resource and the required facilities are in place. However, Africa has the lowest cardiac centres at 1 to 33 million population compared to Asia: 1 to16 million, Europe: 1 to1 million and USA: 1 to 12 hundred thousand people. East Africa has 12 cardiac units/centres in a population of approximately 200 million. Tanzania, the partner state hosting the East African Centre of Excellence for Cardiovascular Sciences, has only 2 cardiac centres in a population of 60 million. In terms of human resource, Africa has a severe shortage of cardiac specialists, for example a cardiac surgeon (for adults): population ratio is 1:25 million population in Sub Saharan Africa, while the global ratio for the same is 1.6 (range 0-181) per 1 million population.

The direct beneficiaries are: i) MUHAS staff and students from Tanzania and the EAC region who will benefit from training, and ii) cardiovascular disease patients from Tanzania, the EAC region and elsewhere, who will benefit from treatment and rehabilitation services at the facility. As a national project, the immediate target beneficiaries are Tanzanian citizens, but as a highly specialized teaching hospital, students and patients from other EAC countries and beyond are expected to benefit from the treatment services. A total of 100 students (45% female) and 120 MUHAS faculty members (45% female) will be trained to help develop a pool of highly qualified and competitive cardiovascular scientists in the country, the EAC region and Africa in general. This training will complement the 38 MUHAS teachers trained in the first phase. It is estimated that 20% of the students will benefit from a full scholarship. These include qualified young people from disadvantaged or poor socio-economic backgrounds, particularly women and people with disabilities.

Investment Description
Here you can find a list of individual development financial institutions that finance the project.

Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.

Hamisi Seif SIMBA
Social Development Officer, AHHD1
African Development Bank
h.simba@afdb.org 
www.afdb.org 

ACCESS TO INFORMATION

You can submit an information request for project information at: https://www.afdb.org/en/disclosure-and-access-to-information/request-for-documents. Under the AfDBÕs Disclosure and Access to Information policy, if you feel the Bank has omitted to publish information or your request for information is unreasonably denied, you can file an appeal at https://www.afdb.org/en/disclosure-and-access-to-information/appeals-process  

ACCOUNTABILITY MECHANISM OF AfDB

The Independent Review Mechanism (IRM), which is administered by the Compliance Review and Mediation Unit (CRMU), is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an African Development Bank (AfDB)-financed project. If you submit a complaint to the IRM, it may assist you by either seeking to address your problems by facilitating a dispute resolution dialogue between you and those implementing the project and/or investigating whether the AfDB complied with its policies to prevent environmental and social harms. You can submit a complaint electronically by emailing crmuinfo@afdb.org, b.kargougou@afdb.org, b.fall@afdb.org, and/or s.toure@afdb.org. You can learn more about the IRM and how to file a complaint at: https://www.afdb.org/en/independent-review-mechanism/  

How it works

How it works